NCT03837925View on ClinicalTrials.gov

Pharmaco-metabolomic Effects of Statins: METASTATINE

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions
Cardiovascular Diseases
Interventions
DRUG

Atorvastatin 40mg Tablet

Patient participation for 6 weeks of treatment

DRUG

Placebo comparator

Patient participation for 6 weeks of treatment

Trial Locations (2)

75013

CIC La Sapétrière, Paris

75015

CIC HEGP, Paris

Sponsors
All Listed Sponsors
collaborator

Fondation Coeur et Recherche

UNKNOWN

collaborator

ICAN Nutrition Education and Research

INDUSTRY

collaborator

Fédération francaise de cardiologie

UNKNOWN

lead

French Cardiology Society

OTHER